Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1977 Jun;78(3):419–427. doi: 10.1017/s002217240005631x

Rubella in Orkney: seroepidemiology and vaccination

Margaret A J Moffat, S N Heywood, Eileen Laughton, Janine J Gould, D S Freestone
PMCID: PMC2129886  PMID: 266542

Abstract

Rubella haemagglutination inhibiting (HAI) antibody titres were determined in 54 seronegative women and 31 naturally immune women after vaccination and revaccination with Wistar RA27/3 strain rubella vaccine administered by the intranasal or subcutaneous routes or revaccination with the Cendehill strain administered subcutaneously. In addition, HAI antibody titres were determined in 46 seronegative schoolgirls after vaccination with the Cendehill strain and revaccination with the RA27/3 strain.

All seronegative women vaccinated with the RA27/3 strain developed antibody, peak titres being reached 6 weeks after vaccination. Six months after vaccination with the Cendehill strain, 45 (98%) of the 46 seronegative girls had developed antibody, but 11 (24%) had not reached their peak titre by 6 weeks, suggesting a slower response than that elicited by the RA27/3 strain. Revaccination did not induce significant antibody responses in the seronegative women vaccinated 6 months previously with RA27/3 but 4 naturally immune women developed an eightfold increase in antibody. In 10 (22%) of 46 schoolgirls previously vaccinated with the Cendehill strain a significant rise in antibody followed revaccination with RA27/3. These results provide further evidence of the more rapid antibody responses elicited by the RA27/3 vaccine in comparison with the Cendehill vaccine.

An outbreak of natural rubella occurred in 1972 and 97 cases were confirmed serologically. The clinical disease was more common in older school-children and in adults. More males than females were affected in the 11-15 age group, the sex ratio being 18:12; this may be explained by the routine vaccination of girls of this age group as part of the national programme which began in 1970. The significance of the persistence of high HAI antibody titres after natural infection and the effect of the epidemic on the serological status of the population are discussed.

Full text

PDF
419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown T., Hambling M. H., Ansari B. M. Rubella-neutralizing and haemagglutinin-inhibiting antibodies in children of different ages. Br Med J. 1969 Nov 1;4(5678):263–265. doi: 10.1136/bmj.4.5678.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chang T. W. Editorial: Rubella reinfection and intrauterine involvement. J Pediatr. 1974 Apr;84(4):617–618. doi: 10.1016/s0022-3476(74)80706-7. [DOI] [PubMed] [Google Scholar]
  3. Fogel A., Moshkowitz A., Rannon L., Gerichter C. B. Comparative trials of RA 27-3 and Cendehill rubella vaccines in adult and adolescent females. Am J Epidemiol. 1971 May;93(5):392–398. doi: 10.1093/oxfordjournals.aje.a121272. [DOI] [PubMed] [Google Scholar]
  4. Freestone D. S., Reynolds G. M., McKinnon J. A., Prydie J. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley. Br J Prev Soc Med. 1975 Dec;29(4):258–261. doi: 10.1136/jech.29.4.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grillner L. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines. Scand J Infect Dis. 1975;7(3):169–172. doi: 10.3109/inf.1975.7.issue-3.03. [DOI] [PubMed] [Google Scholar]
  6. Hattis R. P., Halstead S. B., Herrmann K. L., Witte J. J. Rubella in an immunized island population. JAMA. 1973 Feb 26;223(9):1019–1021. [PubMed] [Google Scholar]
  7. Moffat M. A., Gould J. J., Forbes F. A., Freestone D. S., Macdonald A. Studies with rubella vaccine (RA 27-3) using the subcutaneous and intranasal routes. Scott Med J. 1972 Apr;17(4):140–142. doi: 10.1177/003693307201700403. [DOI] [PubMed] [Google Scholar]
  8. Paul N. R., Rhodes A. J., Campbell J. B., Labzoffsky N. A. Rubella precipitin response in natural infection and in vaccination. Arch Gesamte Virusforsch. 1974;45(4):335–351. doi: 10.1007/BF01242877. [DOI] [PubMed] [Google Scholar]
  9. Plotkin S. A., Farquhar J. D., Ogra P. L. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA. 1973 Aug 6;225(6):585–590. doi: 10.1001/jama.225.6.585. [DOI] [PubMed] [Google Scholar]
  10. SEVER J. L., SCHIFF G. M., BELL J. A., KAPIKIAN A. Z., HUEBNER R. J., TRAUB R. G. RUBELLA: FREQUENCY OF ANTIBODY AMONG CHILDREN AND ADULTS. Pediatrics. 1965 Jun;35:996–998. [PubMed] [Google Scholar]
  11. Thomssen R. Vergleich der Antikörperbildung nach parenteraler Schutzimpfung mit den Rubella-Impfstoffen "Cendehill" und RA 27-3. Dtsch Med Wochenschr. 1973 Aug 24;98(34):1555–1559. doi: 10.1055/s-0028-1107080. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES